Kristina Karandasheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kristina Karandasheva has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr Vyacheslavovich Levov
Moscow State Budgetary Healthcare Institution, Morozovkaya Children’s City Clinica Hospital of the Moscow City Healthcare Department, Moscow, Russia
1 shared publication - Aleksey N. Kislyakov
Morozov Children’s Clinical Hospital
1 shared publication - Ekaterina V. Bychkova
Research Centre for Medical Genetics, Moscow 115522, Russia
1 shared publication - Kirill Igorevich Anoshkin
Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany
1 shared publication - Marina Yuryevna Dorofeyeva
Pirogov Russian National Research Medical University
1 shared publication - Vladimir Strelnikov
Research Centre for Medical Genetics, 115522 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 3 May 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (5) , 3977-3996
Specific Features of Focal Cortical Dysplasia in Tuberous Sclerosis Complex
Patients with tuberous sclerosis complex present with cognitive, behavioral, and psychiatric impairments, such as intellectual disabilities, autism spectrum disorders, and drug-resistant epilepsy. It has been shown that these disorders are associated with the presence of cortical tubers. Tuberous sclerosis complex results from inactivating mutations in the TSC1 or TSC2 genes, resulting in hyperactivation of the mTOR signaling pathway, which regulates cell growth, proliferation, survival, and autophagy. TSC1 and TSC2 are classified as tumor suppressor genes and function according to Knudson’s two-hit hypothesis, which requires both alleles to be damaged for tumor formation. However, a second-hit mutation is a rare event in cortical tubers. This suggests that the molecular mechanism of cortical tuber formation may be more complicated and requires further research. This review highlights the issues of molecular genetics and genotype–phenotype correlations, considers histopathological characteristics and the mechanism of morphogenesis of cortical tubers, and also presents data on the relationship between these formations and the development of neurological manifestations, as well as treatment options.
- 3 May 2023
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 45 (5) , 3977-3996
Open AccessSpecific Features of Focal Cortical Dysplasia in Tuberous Sclerosis Complex
Patients with tuberous sclerosis complex present with cognitive, behavioral, and psychiatric impairments, such as intellectual disabilities, autism spectrum disorders, and drug-resistant epilepsy. It has been shown that these disorders are associated with the presence of cortical tubers. Tuberous sclerosis complex results from inactivating mutations in the TSC1 or TSC2 genes, resulting in hyperactivation of the mTOR signaling pathway, which regulates cell growth, proliferation, survival, and autophagy. TSC1 and TSC2 are classified as tumor suppressor genes and function according to Knudson’s two-hit hypothesis, which requires both alleles to be damaged for tumor formation. However, a second-hit mutation is a rare event in cortical tubers. This suggests that the molecular mechanism of cortical tuber formation may be more complicated and requires further research. This review highlights the issues of molecular genetics and genotype–phenotype correlations, considers histopathological characteristics and the mechanism of morphogenesis of cortical tubers, and also presents data on the relationship between these formations and the development of neurological manifestations, as well as treatment options.